Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases.

International Journal of Biological Macromolecules
Nisha GulatiHarish Dureja

Abstract

Chitosan-loaded nanomedicines provide a greater opportunity for the treatment of respiratory diseases. Natural biopolymer chitosan and its derivatives have a large number of proven pharmacological actions like antioxidant, wound healing, immuno-stimulant, hypocholesterolemic, antimicrobial, obesity treatment, anti-inflammatory, anticancer, bone tissue engineering, antifungal, regenerative medicine, anti-diabetic and mucosal adjuvant, etc. which attracted its use in the pharmaceutical industry. As compared to other polysaccharides, chitosan has excellent mucoadhesive characteristics, less viscous, easily modified into the chemical and biological molecule and gel-forming property due to which the drugs retain in the respiratory tract for a longer period of time providing enhanced therapeutic action of the drug. Chitosan-based nanomedicines would have the greatest effect when used to transport poor water soluble drugs, macromolecules like proteins, and peptides through the lungs. In this review, we highlight and discuss the role of chitosan and its nanomedicines in the treatment of chronic respiratory diseases such as pneumonia, asthma, COPD, lung cancer, tuberculosis, and COVID-19.

References

Jan 7, 1999·Drug Development and Industrial Pharmacy·O FeltR Gurny
Apr 10, 2004·International Journal of Pharmaceutics·V R SinhaS Dhawan
Feb 10, 2009·Colloids and Surfaces. B, Biointerfaces·Marco ZaruSophia G Antimisiaris
May 27, 2009·International Journal of Pharmaceutics·F A Oyarzun-AmpueroM J Alonso
Jul 9, 2009·Biotechnology Advances·Mi Lan KangHan Sang Yoo
Jul 14, 2010·Current Pharmaceutical Design·Qingxing XuDaniel Wayne Pack
Oct 19, 2010·International Journal of Food Microbiology·Ming KongHyun Jin Park
May 9, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andreas Bernkop-Schnürch, Sarah Dünnhaupt
Jun 15, 2012·Lipids in Health and Disease·Rahul NairPrasanna Y Raju
Mar 1, 2014·International Journal of Molecular Sciences·Hao WangXiao Zhou
Jul 8, 2014·International Journal of Pharmaceutics·Chompoonuch SawaengsakNuttanan Sinchaipanid
Mar 27, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Anthony L ByrneGuy B Marks
Feb 16, 2016·International Journal of Pharmaceutics·Elena Fernández FernándezFrancisco M Goycoolea
May 20, 2016·International Journal of Biological Macromolecules·Ashwini KumarAwanish Kumar
Jun 2, 2016·Critical Reviews in Biotechnology·Farnaz AssaAydin Berenjian
Jul 21, 2016·Nanoscale·Nazrul Islam, Vito Ferro
Apr 26, 2017·International Journal of Pharmaceutics·Maria ManconiElias Fattal
Jun 21, 2017·International Journal of Pharmaceutics·Khalid M El-Say, Hossam S El-Sawy
Jul 1, 2017·F1000Research·Sharon R Rosenberg, Ravi Kalhan
Oct 22, 2017·International Journal of Biological Macromolecules·Bijay SinghChong-Su Cho
Dec 6, 2017·International Journal of Pharmaceutics·Alexandre C C VieiraSalette Reis
Dec 19, 2017·International Journal of Biological Macromolecules·Akbar Ali, Shakeel Ahmed
May 26, 2018·Microbial Pathogenesis·Farzad KhademiSaman Soleimanpour
Jul 13, 2018·Pediatric Pulmonology·Erica A RoeschJames F Chmiel
Aug 26, 2018·Carbohydrate Polymers·Makoto AnrakuMasaki Otagiri
Sep 4, 2018·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tejal RawalShital Butani
Sep 13, 2018·Current Stem Cell Research & Therapy·Shabnam MohebbiMasoud Mozafari
Feb 2, 2019·International Journal of Biological Macromolecules·Muhammad NaveedQi-Gang Zhou
Jul 16, 2019·American Journal of Respiratory and Critical Care Medicine·Paula MeekElise Austegard
Aug 14, 2019·International Journal of Biological Macromolecules·Parijat PandeyHarish Dureja
Nov 19, 2019·International Journal of Biological Macromolecules·Prasanna S BakshiN S Kumar
Nov 27, 2019·International Journal of Biological Macromolecules·Hamed HamedinasabMahmoud Reza Jaafari
Feb 29, 2020·International Journal of Biological Macromolecules·Sahil ChaudharyRakesh Sharma
May 29, 2020·International Journal of Biological Macromolecules·Santosh KumarJoonseok Koh
Jun 5, 2020·Recent Patents on Nanotechnology·Parijat PandeyHarish Dureja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Nanomedicine
Funmilola A FisusiIjeoma F Uchegbu
Molecular Pharmaceutics
Chung Hang Jonathan Choi, May P Xiong
Nanomedicine : Nanotechnology, Biology, and Medicine
Frank J Malinoski
© 2021 Meta ULC. All rights reserved